SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-072796
Filing Date
2024-06-18
Accepted
2024-06-18 16:05:19
Documents
2
Period of Report
2024-06-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2417524-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2417524-1_3seq1.xml 3 1633
2 EXHIBIT 24 tm2417524d1_ex24.htm EX-24 8841
  Complete submission text file 0001104659-24-072796.txt   12225
Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Issuer) CIK: 0001828185 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O BARINTHUS BIOTHERAPEUTICS PLC. UNIT 6-10, ZEUS BUILDING, RUTHERFORD AVE HARWELL X0 OX11 0DF
Business Address
Hooftman Leon (Reporting) CIK: 0002027157 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40367 | Film No.: 241051698